Poolbeg Pharma plc

Poolbeg Pharma plc

Focused on the development & commercialisation of innovative medicines. Ticker: POLB

Founded 2021

London, United Kingdom 15 employees Grant Biotechnology, Pharmaceutical

Poolbeg Pharma plc is a UK-based biotechnology and pharmaceutical company with a commitment to developing and commercializing innovative medicines targeting diseases with high unmet medical needs, particularly rare and orphan diseases. The company's unique model focuses on the development of clinical assets and the commercialization of approved drugs to fund its robust pipeline of innovative products, aiming to drive significant value creation. The leadership team of Poolbeg Pharma plc is highly experienced and has a successful track record of delivering value to shareholders. Notably, the team has been reinforced by the addition of three former members of the Amryt Pharma plc leadership team, with the goal of replicating Amryt's achievements and generating near-term revenues. Poolbeg Pharma plc's clinical programmes target large addressable markets, including cancer immunotherapy-induced CRS, infectious disease, and metabolic conditions such as obesity, where they are developing an oral GLP-1R agonist. The company follows a cost-effective development approach to generate high-quality human data, supporting partnering and further development. Additionally, its AI-led infectious disease programmes leverage unique data from human challenge trials to identify clinically relevant drug targets and treatments, facilitating faster development and increased commercial appeal. The latest investment in Poolbeg Pharma plc was a grant investment on 22 June 2023, with funding provided by the Department of Enterprise, Trade and Employment and RS Participaties. This investment emphasizes confidence in the company's potential and its innovative approach to addressing unmet medical needs in the biotechnology and pharmaceutical industries.

Funding Stage	Amount	Investors	Lead Investors	Date
Grant	Undisclosed	2	Department of Enterprise, Trade and Employment, RS Participaties	22 Jun 2023

Funding Stage

Amount

Investors

Lead Investors

Date

Grant

Undisclosed

Department of Enterprise, Trade and Employment, RS Participaties

22 Jun 2023

FAQ About Poolbeg Pharma plc

Focused on the development & commercialisation of innovative medicines. Ticker: POLB

Poolbeg Pharma plc was founded in 2021.

Poolbeg Pharma plc is headquartered in London, United Kingdom.

Poolbeg Pharma plc operates in Biotechnology and Pharmaceutical. Its work centres on pharmaceuticals, clinical-stage, cancer immunotherapy and oncology.

Poolbeg Pharma plc has approximately 15 employees.

Poolbeg Pharma plc has completed 1 funding round. The latest funding stage is Grant.

Top alternatives and competitors to Poolbeg Pharma plc include Aston Sci., IMMUNITOR Ltd., Acer Therapeutics Inc., Santaris Pharma, Terns Pharmaceuticals. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Poolbeg Pharma plc and Aston Sci. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About Poolbeg Pharma plc

Funding Rounds & Investors (1)

Poolbeg Pharma plc Alternatives & Competitors

FAQ About Poolbeg Pharma plc